Stock Analysis of Aadi Bioscience Inc (AADI) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code AADI
Close 5.13
Change 0.140 / 2.81 %
Volume 79516.00
Vol Change -16142.00 / 16.87 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of Aadi Bioscience Inc
PE (TTM)

-361.83

Very Poor
Price / Book

239.03

Very Poor
Price / Sales

1192.01

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

125817 K

Enterprise Value

87192.87 K

ROA (TTM)

-56.87

Very Poor
ROE (TTM)

-66.06

Very Poor
Net Margin (TTM)

-329.44

Very Poor
Revenue

1421.60 %

15216.00 K
Net Profit

45.03 %

-60513.00 K
Debt to Equity

0.0025

Excellent
Altman Z Score

1.41

Not Good
Quick Ratio

9.46

Excellent
Cash Ratio

9.16

Excellent


Highs/Lows of Aadi Bioscience Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week4.75 8.00 % 0.425 % 5.74.7229-Nov-2328-Nov-23
Two Week4.75 8.00 % 0.493 % 5.74.6629-Nov-2327-Nov-23
One Month4.86 5.56 % 4.85 % 5.74.429-Nov-2309-Nov-23
Three Month5.86 12.46 % 1.20 % 6.2873.8813-Sep-2319-Oct-23
Six Months8.06 36.35 % 6.71 % 8.4453.8816-Jun-2319-Oct-23
One year13.4 61.72 % 12.23 % 13.63.8805-Dec-2219-Oct-23
Two year19.32 73.45 % 0.691 % 11.913.8816-Feb-2319-Oct-23
Five year31.5 83.71 % 69.25 % 14.7723.8803-Oct-2219-Oct-23


Technical View of Aadi Bioscience Inc
RSI

43.58

Neutral
MACD

-0.249

Bullish
ADX

19.94

Neutral
Super Trend

4.84

Mild Bearish
Williams %R

-57.47

Neutral
CCI

25.14

Neutral


EMA 5

4.22

Bullish
EMA 15

4.27

Whipsaw
EMA 50

4.93

Mild Bearish
EMA 100

5.79

Mild Bearish
SMA 100

5.82

Mild Bearish
SMA 200

7.54

Strong Bearish
SMA 5 / 20

4.20 / 4.22

Mild Bearish
SMA 15 / 50

4.21 / 5.13

Strong Bearish
SMA 50 / 200

5.13 / 7.54

Mild Bearish




Charts of Aadi Bioscience Inc


Returns of Aadi Bioscience Inc with Peers
Period / StockAADIIMABANNXGALT
1 Week8.00%0%-10.90%1.51%
1 Mth5.56%-16.39%-8.49%0.498%
3 Mth-12.46%-21.13%-18.56%14.77%
6mth-36.35%-51.89%-20.47%28.66%
1 Year-61.72%-59.95%-55.78%65.57%
2 Year-73.45%-97.10%-84.95%-11.40%
5 Years-83.71%-59.03%


Compare Fundamentals of Aadi Bioscience Inc with Peers
Ratio / StockAADIIMABANNXGALT
PE-361.83-0.059-318.07-1.96
P/B239.030.053213.51-3.02
ROA-56.87-68.79-53.98-301.22
ROE-66.06-90.25-67.130
Debt To Equity0.00250.01430.0057-1.18
Revenue15216.00 K
1421.60 % 		-221563.00 K
351.70 % 		0
% 		0
%
Net Income-60513.00 K
45.03 % 		-2411.82 M
3.44 % 		-141947.00 K
8.92 % 		-38776.00 K
27.02 %


Technicals of Aadi Bioscience Inc with Peers
Technical / StockAADIIMABANNXGALT
ADX17.7519.3924.2913.00
CMF-0.03780.072-0.153-0.155
MFI61.4053.9636.6747.70
RSI58.3149.0248.9152.31
MACD Abv SignalTrueFalseFalseTrue
Price Above 50 MATrueTrueTrueTrue
Price Above 200 MAFalseFalseFalseTrue


About : Aadi Bioscience Inc

Address : 17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272
Tel : 424 473 8055
URL : https://aadibio.com
Code : AADI, ISIN : US00032Q1040, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 08_Aug_2017
Employee Count : 88

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus bound to albumin. The company is also involved in evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.


Note : All Data Generated at the End of Trading Hours (EOD Data)